281 related articles for article (PubMed ID: 21123490)
1. A PPARgamma agonist inhibits aldosterone-induced mesangial cell proliferation by blocking ROS-dependent EGFR intracellular signaling.
Yuan Y; Zhang A; Huang S; Ding G; Chen R
Am J Physiol Renal Physiol; 2011 Feb; 300(2):F393-402. PubMed ID: 21123490
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation.
Huang S; Zhang A; Ding G; Chen R
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1323-33. PubMed ID: 19339632
[TBL] [Abstract][Full Text] [Related]
3. Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor gamma.
Li X; Yang X; Xu Y; Jiang X; Li X; Nan F; Tang H
Cell Res; 2009 Jun; 19(6):720-32. PubMed ID: 19417774
[TBL] [Abstract][Full Text] [Related]
4. Activation of PPAR{gamma} by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR.
Chen A; Xu J
Am J Physiol Gastrointest Liver Physiol; 2005 Mar; 288(3):G447-56. PubMed ID: 15486348
[TBL] [Abstract][Full Text] [Related]
5. Rosiglitazone induces caveolin-1 by PPARgamma-dependent and PPRE-independent mechanisms: the role of EGF receptor signaling and its effect on cancer cell drug resistance.
Tencer L; Burgermeister E; Ebert MP; Liscovitch M
Anticancer Res; 2008; 28(2A):895-906. PubMed ID: 18507034
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone attenuates epidermal growth factor receptor signaling independently of peroxisome proliferator-activated receptor in PC-3 cells.
Zhu H; Pan X; Qi H; Wang X; Hou S; Han B; Liu Z; Xu L
Oncol Rep; 2011 Jan; 25(1):81-90. PubMed ID: 21109961
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
Kim KY; Ahn JH; Cheon HG
Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
[TBL] [Abstract][Full Text] [Related]
8. ATP stimulates mouse embryonic stem cell proliferation via protein kinase C, phosphatidylinositol 3-kinase/Akt, and mitogen-activated protein kinase signaling pathways.
Heo JS; Han HJ
Stem Cells; 2006 Dec; 24(12):2637-48. PubMed ID: 16916926
[TBL] [Abstract][Full Text] [Related]
9. Control of PDGF-induced reactive oxygen species (ROS) generation and signal transduction in human lens epithelial cells.
Chen KC; Zhou Y; Zhang W; Lou MF
Mol Vis; 2007 Mar; 13():374-87. PubMed ID: 17392688
[TBL] [Abstract][Full Text] [Related]
10. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
11. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J
J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 phosphorylation is required for stretch-induced EGFR and Akt activation in mesangial cells.
Zhang B; Peng F; Wu D; Ingram AJ; Gao B; Krepinsky JC
Cell Signal; 2007 Aug; 19(8):1690-700. PubMed ID: 17446044
[TBL] [Abstract][Full Text] [Related]
13. Activation of peroxisome proliferator-activated receptor gamma inhibits cell growth via apoptosis and arrest of the cell cycle in human colorectal cancer.
Lin MS; Chen WC; Bai X; Wang YD
J Dig Dis; 2007 May; 8(2):82-8. PubMed ID: 17532820
[TBL] [Abstract][Full Text] [Related]
14. Phorbol ester potentiates the growth inhibitory effects of troglitazone via up-regulation of PPARgamma in A549 cells.
Kim HJ; Woo IS; Kang ES; Eun SY; Kim GH; Ham SA; Kim HJ; Lee JH; Chang KC; Kim JH; Lee HT; Seo HG
Biochem Biophys Res Commun; 2006 Oct; 349(2):660-7. PubMed ID: 16945329
[TBL] [Abstract][Full Text] [Related]
15. Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration.
Zhuang S; Dang Y; Schnellmann RG
Am J Physiol Renal Physiol; 2004 Sep; 287(3):F365-72. PubMed ID: 15213065
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of KR-62980, a new PPARγ agonist, against chemical ischemia-reperfusion in SK-N-SH cells.
Kim KY; Cho HS; Lee SH; Ahn JH; Cheon HG
Brain Res; 2011 Feb; 1372():103-14. PubMed ID: 21111719
[TBL] [Abstract][Full Text] [Related]
17. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
Díaz-Delfín J; Morales M; Caelles C
Diabetes; 2007 Jul; 56(7):1865-71. PubMed ID: 17416798
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
19. ANG II induces c-Jun NH2-terminal kinase activation and proliferation of human mesangial cells via redox-sensitive transactivation of the EGFR.
Ding G; Zhang A; Huang S; Pan X; Zhen G; Chen R; Yang T
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1889-97. PubMed ID: 17881465
[TBL] [Abstract][Full Text] [Related]
20. SREBP-1 activation by glucose mediates TGF-β upregulation in mesangial cells.
Uttarwar L; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2012 Feb; 302(3):F329-41. PubMed ID: 22031849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
